sar425899 dual agonist glp-1 glucagon sanofi Focus on Glucagon-like Peptide- 1 Target: Drugs Approved or Designed to Treat Obesity Receptor occupancy of dual glucagon-like – Design of Novel Exendin-Based Dual
Pay in 4 interest-free payments of $5.20 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7


























